Novartis AG

NVS | NYSE

Price Alert Chart Builder DCF Calculator

$143.57

+$0.86 (+0.60%)

At close: Sep 24, 2026, 4:00 PM ET

$143.36

-$0.21 (-0.15%)

After-hours: Sep 24, 2026, 5:01 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	14.06B	11.94B	8.57B	6.05B	22.91B	8.07B
Depreciation & Amortization	5.35B	6.07B	8.28B	6.71B	5.6B	6.46B
Stock-Based Compensation	n/a	1.04B	865M	791M	700M	738M
Other Working Capital	-1.71B	555M	1.2B	342M	492M	439M
Other Non-Cash Items	3.27B	-2.43B	-3.44B	359M	-15.68B	-3.14B
Deferred Income Tax	-361.84M	1.7B	551M	1.13B	1.63B	1.81B
Change in Working Capital	-3.08B	-706M	-369M	-796M	-73M	-291M
Operating Cash Flow	19.24B	17.62B	14.46B	14.24B	15.07B	13.65B
Capital Expenditures	-1.56B	-3.81B	-2.75B	-2.24B	-2.56B	-2.59B
Cash Acquisitions	-3.01B	-3.83B	-3.57B	-864M	20.46B	-9.96B
Purchase of Investments	-304.55M	-3.65B	-747M	-34.81B	-16.59B	-2.13B
Sales Maturities Of Investments	2.19B	3.7B	11.6B	39.49B	2.74B	1.22B
Other Investing Acitivies	140.72M	-2.38B	-624M	-1.43B	-1.34B	282M
Investing Cash Flow	-4.9B	-7.51B	5.6B	1.47B	4.21B	-13.18B
Debt Repayment	2.72B	4.39B	-1.94B	-2.59B	-5.67B	7.07B
Common Stock Repurchased	-9.26B	-8.33B	-8.72B	-10.65B	-3.06B	-2.84B
Dividend Paid	-7.86B	-7.62B	-7.26B	-7.51B	-7.37B	-6.99B
Other Financial Acitivies	-577.95M	-177M	3.63B	181M	-169M	549M
Financial Cash Flow	-14.94B	-11.74B	-14.28B	-20.56B	-16.26B	-2.21B
Net Cash Flow	-24M	-1.93B	5.88B	-4.89B	2.75B	-1.45B
Free Cash Flow	17.69B	13.81B	11.71B	12B	12.52B	11.07B
Adj. Free Cash Flow	17.69B	12.76B	10.84B	11.21B	11.82B	10.33B
Maintenance CapEx	-762.36M	-2.43B	-1.8B	-2.24B	-2.56B	-2.2B
Growth CapEx	-793.57M	-1.39B	-953.91M	n/a	n/a	-384.14M
Owner Earnings	18.48B	15.19B	12.66B	12B	12.52B	11.45B